Sartorius to acquire TAP Biosystems
8 Oct 2013
Sartorius Stedim Biotech announced yesterday that it has made an offer to buy fermentation specialist TAP Biosystems, pending shareholder approval.
The deal, which has been unanimously approved by the board of directors from both companies, is expected to close at the end of 2013.
TAP Biosystems specialises in the design and development of small-scale, multi-parallel fermentation systems particularly for biopharmaceutical applications. Furthermore, TAP Biosystem’s portfolio includes automated cell processing systems and other bench top equipment.
Chief executive of Sartorius Joachim Kreuzberg said: “TAP Biosystems’ fermentors are a great fit extending our reach into the small scale cell culture applications.
“Adding capabilities in the early steps of upstream bioprocessing will enable us to provide our biopharma customers highly effective and scalable solutions to accelerate cell line selection, speed-up process development and ultimately help them bringing their biologics to market faster.”
Further details of the acquisition are yet to be published.
